Pathophysiology and diagnosis of primary hyperparathyroidism - strategy for asymptomatic primary hyperparathyroidism

Citation
M. Inaba et al., Pathophysiology and diagnosis of primary hyperparathyroidism - strategy for asymptomatic primary hyperparathyroidism, BIOMED PHAR, 54, 2000, pp. 7S-11S
Citations number
17
Categorie Soggetti
Pharmacology & Toxicology
Journal title
BIOMEDICINE & PHARMACOTHERAPY
ISSN journal
07533322 → ACNP
Volume
54
Year of publication
2000
Supplement
1
Pages
7S - 11S
Database
ISI
SICI code
0753-3322(200006)54:<7S:PADOPH>2.0.ZU;2-0
Abstract
Primary hyperparathyroidism (PHPT), the most common cause of hypercalcemia due to excessive secretion of PTH, is usually associated with hypophosphate mia and elevated serum chloride. Although PHPT was often complicated by ren al stone disease and osteitis fibrosa in the past, routine screening of ser um calcium (Ca) and development of sophisticated assay of parathyroid hormo ne have contributed to earlier detection of asymptomatic PHPT (APHPT). The proportion of APHPT patients, who have a mild elevation of serum Ca levels, usually within 1.0 mg/dL above the upper limit of normal, rose from 10-20% to approximately 45% of all PHPT patients in 1990-1995 in our clinic. Alth ough it has been reported that the prevalence of PHPT is about 0.1% of the American population, the prevalence of PHPT appears to be far less in the J apanese population. Determination of a strategy for the increasing number o f APHPT patients is a pressing need but has yet to be accomplished. Treatme nt with bone antiresorptive drugs has met with some success, although the l ong-term efficacy of this treatment is not clear. The therapeutic effects o f Ca-sensing receptor agonists appear promising. (C) 2000 Editions scientif iques et medicales Elsevier SAS.